MedTrace Logo

Cingal Study for Knee Osteoarthritis

NCT01891396 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 368

Last updated 2023-06-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if a single injection of Cingal into the knee provides safe relief of pain caused by osteoarthritis.

Conditions

Interventions

DEVICE

Hyaluronic Acid and TH (Cingal®)

Injection into knee

DEVICE

Hyaluronic Acid (Monovisc®)

Injection into knee

DEVICE

Saline

Saline placebo packaged to look identical to comparator syringes. Injection into knee.

Sponsors & Collaborators

  • Anika Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Laszlo Hangody, MD · Uzsoki Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-05-31
Completion
2014-09-30

Countries

  • Bulgaria
  • Canada
  • Czechia
  • Hungary
  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01891396 on ClinicalTrials.gov